Ucb, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 00131 (Ucb, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
14
Package NDCs
6
Products
6
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
3
Dosage forms
9
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 6 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Vimpat lacosamide 10 mg/mL SOLUTION | 00131-5410-70 | — | Discontinued | View → |
| Vimpat lacosamide 100 mg/1 TABLET, FILM COATED | 00131-2478-35 | $18.537 /unit · NADAC | On market | View → |
| Vimpat lacosamide 150 mg/1 TABLET, FILM COATED | 00131-2479-35 | $19.646 /unit · NADAC | On market | View → |
| Vimpat lacosamide 50 mg/1 TABLET, FILM COATED | 00131-2477-35 | $11.822 /unit · NADAC | On market | View → |
| Vimpat lacosamide 10 mg/mL INJECTION | 00131-1810-67 | — | On market | View → |
| Vimpat lacosamide 200 mg/1 TABLET, FILM COATED | 00131-2480-35 | $19.627 /unit · NADAC | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.